synthetic biology
The funds will allow Rice University researchers to build a functional prototype of THOR, a device that senses tumor growth and manufactures drugs to treat cancers in real time.
Kite Pharma Licenses Refuge Biotechnologies Platform to Bolster CAR T-Cell Therapy Development
The Gilead subsidiary will use Refuge's synthetic biology platform to develop treatments for blood cancers, while Refuge will retain its rights for solid tumor drug development.